Results 251 to 260 of about 1,097,866 (354)
Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan. [PDF]
Al Anber A +6 more
europepmc +1 more source
The preferred derivative JX3212 demonstrates strong inhibitory activity against Kir4.1 with favorable druggability and shows significant antidepressant efficacy in vivo. Abstract Major depressive disorder is a serious psychiatric disorder for which novel and fast‐acting antidepressants are required.
Sisi Wang +15 more
wiley +1 more source
Phosphorylation of Optineurin by TBK1 induces the formation of filaments that condensate upon binding to linear polyubiquitin. Membrane‐anchored LC3 partitions into these condensates, suggesting that phase separation of filamentous Optineurin with ubiquitylated cargo promotes the sequestration of cargo and its subsequent alignment with LC3‐positive ...
Maria G. Herrera +10 more
wiley +1 more source
Liver Cirrhosis With Encapsulating Peritoneal Sclerosis: A Case Report. [PDF]
Boudreau E, Matte R, Wilke C.
europepmc +1 more source
Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3
In MASLD, YTHDC1 undergoes increased lactylation and ubiquitination, reducing its expression. AARS1 mediates lactylation at lysine 565, while disrupted binding to LDHA further promotes lactylation, suppressing YTHDC1. This downregulation enhances PTPN22 mRNA stability, leading to NLRP3 dephosphorylation and activation, which exacerbates inflammation ...
Feng Zhang +16 more
wiley +1 more source
Shagreen Patch in Tuberous Sclerosis Complex at High-Frequency Ultrasound. [PDF]
Tagliati C, Wortsman X.
europepmc +1 more source
Interaction between Th17 and central nervous system in multiple sclerosis
Song Lai +5 more
openalex +1 more source
Syntaxin 1A gene polymorphism in multiple sclerosis: a case–control study [PDF]
Mohammed I. Oraby +4 more
openalex +1 more source

